ATE48231T1 - Makromolekulare cdp-cholinderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel. - Google Patents

Makromolekulare cdp-cholinderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel.

Info

Publication number
ATE48231T1
ATE48231T1 AT86113539T AT86113539T ATE48231T1 AT E48231 T1 ATE48231 T1 AT E48231T1 AT 86113539 T AT86113539 T AT 86113539T AT 86113539 T AT86113539 T AT 86113539T AT E48231 T1 ATE48231 T1 AT E48231T1
Authority
AT
Austria
Prior art keywords
cdp
choline
macromolecular
processes
production
Prior art date
Application number
AT86113539T
Other languages
English (en)
Inventor
Vincenzo Zappia
Rosa Mario De
Original Assignee
Vincenzo Zappia
Rosa Mario De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vincenzo Zappia, Rosa Mario De filed Critical Vincenzo Zappia
Application granted granted Critical
Publication of ATE48231T1 publication Critical patent/ATE48231T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT86113539T 1985-10-01 1986-10-01 Makromolekulare cdp-cholinderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel. ATE48231T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22327/85A IT1201474B (it) 1985-10-01 1985-10-01 Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
EP86113539A EP0218190B1 (de) 1985-10-01 1986-10-01 Makromolekulare CDP-Cholinderivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATE48231T1 true ATE48231T1 (de) 1989-12-15

Family

ID=11194722

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86113539T ATE48231T1 (de) 1985-10-01 1986-10-01 Makromolekulare cdp-cholinderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel.

Country Status (8)

Country Link
US (1) US4772463A (de)
EP (1) EP0218190B1 (de)
JP (1) JPS62129296A (de)
AT (1) ATE48231T1 (de)
DE (1) DE3667139D1 (de)
ES (1) ES2011767B3 (de)
GR (1) GR3000235T3 (de)
IT (1) IT1201474B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0408668B1 (de) * 1988-10-27 1994-05-11 Massachusetts Institute Of Technology Verfahren zur Steigerung des Phosphatidylcholins in Vivo
DE69132656T2 (de) * 1990-10-24 2002-05-08 Masayuki Kuzuya Organische polymerverbindung und ihre herstellung
WO1999033476A1 (en) * 1997-12-24 1999-07-08 Interneuron Pharmaceuticals, Inc. Hyperhydrated citicoline, process and use
WO2001068104A1 (en) 2000-03-16 2001-09-20 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
PT1565055E (pt) 2002-11-08 2013-09-16 Mclean Hospital Corp Compostos para o tratamento da dependência e da privação de tabaco
WO2005122767A1 (en) 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
US7947661B2 (en) 2004-08-11 2011-05-24 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage
CN103509073B (zh) * 2013-08-29 2016-01-06 洪军 一种胞磷胆碱钠化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2402664A1 (fr) * 1977-09-07 1979-04-06 Agronomique Inst Nat Rech Produits de couplage phosphorylcholine, composes amines procede d'obtention et applications
IT1207106B (it) * 1980-04-18 1989-05-17 Made Italiana Srl Ora Searle I Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale

Also Published As

Publication number Publication date
IT1201474B (it) 1989-02-02
EP0218190A3 (en) 1987-09-30
EP0218190B1 (de) 1989-11-29
DE3667139D1 (de) 1990-01-04
JPS62129296A (ja) 1987-06-11
EP0218190A2 (de) 1987-04-15
GR3000235T3 (en) 1991-03-15
IT8522327A0 (it) 1985-10-01
ES2011767B3 (es) 1990-02-16
US4772463A (en) 1988-09-20

Similar Documents

Publication Publication Date Title
DK160881C (da) Interpolymer indeholdende indpolymeriserede enheder af acrylsyre, hvis carboxylgrupper er delvis neutraliseret, og af alkylacrylat eller -methacrylat med henholdsvis hoejere og lavere alkylgrupper samt formet genstand omfattende en saadan polymer
KR960703956A (ko) 아크릴릭-포화 고무 하이브리드 감압 접착제
BR9715021A (pt) Polìmeros sensìveis à temperatura e produtos dispersos em água contendo polìmeros
ATE40142T1 (de) Fluessige ueberzugsmasse und verfahren zum ueberziehen von substraten mittels dieser ueberzugsmasse.
DE69615833D1 (de) Klebriggemachte segmentierte polydiorganosiloxan-oligoharnstoff-copolymere sowie verfahren zu deren herstellung
ATE46913T1 (de) Verfahren zur diskontinuierlichen herstellung von vernetzten, feinteiligen polymerisaten.
DE69429338D1 (de) Nicht-nucleosidische cumarin-derivate als reagenzien zum crosslinking von polynucleotiden
BR9815112B1 (pt) processo para a preparaÇço de polÍmeros sintÉticos com teor de monâmero residual muito baixo.
ATE1589T1 (de) Verwendung von (meth)acrylsaeure-maleinsaeurecopolymerisatenals inkrustierungsinhibitoren in waschmitteln.
FR2700549B1 (fr) Procédé de préparation de polymères amine-aldéhyde contenant des groupes sulfo, polymères obtenus selon ce procédé et leur utilisation.
ATE31069T1 (de) Wasserloesliche terpolymere, verfahren zu deren herstellung und verwendung als klebstoff.
DE3869147D1 (de) Copolymer von vinylidenfluorid-acrylsaeureester, verfahren zu dessen herstellung und dieses enthaltende zusammensetzung.
DE3667139D1 (de) Makromolekulare cdp-cholinderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel.
DK0999736T3 (da) Aftagelig beskyttelsesbelægning
FR2483932B1 (fr) Nouvelles compositions polymere acrylique, procede pour leur obtention, et application notamment comme agents antitartres
YU30200A (sh) Postupak za proizvodnju rastvorljivih ili bubrećih u vodi polimerizata vrlo malog sadržaja ostatka monomera, proizvodi prema istom i njihova primena
FR2704752B1 (fr) Composition cosmétique sous forme de gel aqueux.
NZ217231A (en) Sustained release composition containing propionic acid derivative and acrylic, then methacrylic, acid polymer and copolymer coatings
BR9815079A (pt) Processo para a produção de psa's aperfeiçoados
ES2019088B3 (es) Dispersion acuosa de un polimero de adicion, una composicion de recubrimiento basada en ella y un procedimiento para recubrir un sustrato con dicha composicion de recubrimiento.
ATE296322T1 (de) Zusammensetzung
ATE90198T1 (de) Hautschutzmittel.
GB1262692A (en) Acrylic and methacrylic acid esters, polymers thereof and the use of the polymers as agents for gel chromatography
DE3789910D1 (de) Strahlenhärtbare Harzzusammensetzung.
BR9106554A (pt) Processo de aumentar o efeito de uma polissacarideo hidrolase,processo enzimatico que usa uma polissacarideo hidrolase,preparacao de polissacarideo hidrolase,preparacao de endo-glucanase,preparacao de pululanase mista,preparacao de pululanase mista,e,composicao detergente

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee